| scholarly article | Q13442814 |
| P50 | author | Eric O Freed | Q67208349 |
| P2093 | author name string | Naiqian Cheng | |
| Shixing Tang | |||
| Tsutomu Murakami | |||
| Alasdair C. Steven | |||
| Judith G. Levin | |||
| P2860 | cites work | Structural insights into the catalytic mechanism of cyclophilin A | Q24301154 |
| Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition | Q24673418 | ||
| Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection | Q24673913 | ||
| MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures | Q26778412 | ||
| Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein | Q27639039 | ||
| Crystal structure of dimeric HIV-1 capsid protein | Q27733334 | ||
| Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid | Q27734262 | ||
| Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein | Q27746461 | ||
| Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection | Q28646834 | ||
| Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone | Q29547734 | ||
| Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B | Q29618922 | ||
| Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants. | Q30327614 | ||
| Cyclophilin A-induced alterations of human immunodeficiency virus type 1 CA protein in vitro | Q30428149 | ||
| Retrovirus capsid protein assembly arrangements | Q30873476 | ||
| Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. | Q33685950 | ||
| Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag). | Q33807166 | ||
| Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity | Q33813747 | ||
| Association of Nef with the human immunodeficiency virus type 1 core | Q33821376 | ||
| Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions | Q33844210 | ||
| Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells | Q33845811 | ||
| Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. | Q33851147 | ||
| Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. | Q33852465 | ||
| Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences | Q33930053 | ||
| Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A | Q34024214 | ||
| Structural biology of HIV. | Q34068223 | ||
| Assembling the human immunodeficiency virus type 1. | Q34148871 | ||
| p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease | Q34288376 | ||
| Functional association of cyclophilin A with HIV-1 virions | Q34326356 | ||
| Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication | Q34364648 | ||
| Treatment of human immunodeficiency virus type 1 virions depleted of cyclophilin A by natural endogenous reverse transcription restores infectivity | Q34782333 | ||
| Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. | Q35830898 | ||
| Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. | Q35835956 | ||
| Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription | Q35861172 | ||
| The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle | Q35873645 | ||
| Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. | Q36632356 | ||
| Functional domains of the capsid protein of human immunodeficiency virus type 1 | Q36638060 | ||
| Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants | Q36650299 | ||
| Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. | Q36684088 | ||
| A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity | Q36756570 | ||
| The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors | Q36881276 | ||
| Specific incorporation of cyclophilin A into HIV-1 virions | Q38302257 | ||
| Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. | Q39579012 | ||
| N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles | Q39580545 | ||
| Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. | Q39588178 | ||
| Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein. | Q39602742 | ||
| Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex | Q39736736 | ||
| Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein | Q39748566 | ||
| Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. | Q39880513 | ||
| Effects of gag mutations on human immunodeficiency virus type 1 particle assembly, processing, and cyclophilin A incorporation | Q40706744 | ||
| In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. | Q40959792 | ||
| Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly | Q41047831 | ||
| Amino acid substitutions in the CA protein of Moloney murine leukemia virus that block early events in infection | Q41174834 | ||
| Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain | Q41299810 | ||
| Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. | Q41629680 | ||
| Image reconstructions of helical assemblies of the HIV-1 CA protein | Q41631451 | ||
| HIV: early virus-cell interactions | Q41748918 | ||
| Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction | Q42554107 | ||
| A conformational switch controlling HIV-1 morphogenesis | Q42690194 | ||
| HIV-1 gag proteins: diverse functions in the virus life cycle | Q43783202 | ||
| Antiviral inhibition of the HIV-1 capsid protein | Q44380725 | ||
| Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing | Q45252128 | ||
| Characterization of a human immunodeficiency virus type 1 pre-integration complex in which the majority of the cDNA is resistant to DNase I digestion | Q45730867 | ||
| Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid | Q45749967 | ||
| Generation of HIV-1/HIV-2 cross-reactive peptide antisera by small sequence changes in HIV-1 reverse transcriptase and integrase immunizing peptides | Q47789870 | ||
| Assembly and analysis of conical models for the HIV-1 core. | Q52228420 | ||
| Form, function, and use of retroviral gag proteins | Q67961638 | ||
| Assembly and morphology of HIV: potential effect of structure on viral function | Q68251795 | ||
| Structure of the amino-terminal core domain of the HIV-1 capsid protein | Q71142552 | ||
| Characterization of HIV replication complexes early after cell-to-cell infection | Q71602121 | ||
| Molecular recognition in the HIV-1 capsid/cyclophilin A complex | Q73511357 | ||
| Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication | Q73514585 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiology | Q7193 |
| immunology | Q101929 | ||
| P304 | page(s) | 12592-12602 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Human immunodeficiency virus type 1 N-terminal capsid mutants containing cores with abnormally high levels of capsid protein and virtually no reverse transcriptase | |
| Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants Containing Cores with Abnormally High Levels of Capsid Protein and Virtually No Reverse Transcriptase | |||
| P478 | volume | 77 |
| Q40176627 | A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA. |
| Q37780981 | A new functional role of HIV-1 integrase during uncoating of the viral core |
| Q35750243 | A second-site suppressor significantly improves the defective phenotype imposed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein |
| Q40311599 | A small loop in the capsid protein of Moloney murine leukemia virus controls assembly of spherical cores |
| Q42546287 | A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle |
| Q33755116 | ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity |
| Q36845921 | Capsid proteins from human immunodeficiency virus type 1 and simian immunodeficiency virus SIVmac can coassemble into mature cores of infectious viruses. |
| Q36424184 | Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro |
| Q90115233 | Characterization of HIV-1 uncoating in human microglial cell lines |
| Q45046883 | Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle |
| Q40092223 | Characterization of replication defects induced by mutations in the basic domain and C-terminus of HIV-1 matrix |
| Q38903364 | Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells |
| Q36950909 | Contributions of Charged Residues in Structurally Dynamic Capsid Surface Loops to Rous Sarcoma Virus Assembly |
| Q40578149 | Effect of internal cleavage site mutations in human immunodeficiency virus type 1 capsid protein on its structure and function. |
| Q40074644 | Effects of rapid antigen degradation and VEE glycoprotein specificity on immune responses induced by a VEE replicon vaccine |
| Q27490926 | Focus on flaviviruses: current and future drug targets |
| Q56988804 | Forced Complementation between Subgenomic RNAs: Does Human Immunodeficiency Type 1 Virus Reverse Transcription Occur in Viral Core, Cytoplasm, or Early Endosome? |
| Q35635221 | Genetic Studies of the beta-hairpin loop of Rous sarcoma virus capsid protein. |
| Q37447762 | HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. |
| Q36702218 | HIV-1 matrix protein: a mysterious regulator of the viral life cycle |
| Q41690997 | Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells |
| Q41956340 | Isolated HIV-1 core is active for reverse transcription. |
| Q45411655 | Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes |
| Q40326740 | Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. |
| Q43168272 | Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail |
| Q40174170 | Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein |
| Q36496940 | RSV capsid polymorphism correlates with polymerization efficiency and envelope glycoprotein content: implications that nucleation controls morphogenesis. |
| Q44949244 | Resistance of monocyte to HIV-1 infection is not due to uncoating defect |
| Q34775658 | Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription |
| Q33826918 | Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core |
| Q34965309 | Slower uncoating is associated with impaired replicative capability of simian-tropic HIV-1 |
| Q45394517 | Snake venom preparation for drug-resistant human immunodeficiency virus |
| Q55517077 | The KT Jeang Retrovirology prize 2018: Eric Freed. |
| Q37492757 | The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release |
| Q41849464 | The cyclosporin A washout assay to detect HIV-1 uncoating in infected cells |
| Q36614059 | The interdomain linker region of HIV-1 capsid protein is a critical determinant of proper core assembly and stability |
| Q45413360 | The matrix protein of human immunodeficiency virus is cleaved and packed into virion cores |
| Q36329001 | Virion packaging determinants and reverse transcription of SRP RNA in HIV-1 particles |
| Q33718140 | Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain |
Search more.